Updated information and services can be found at: The aac(6)-Iz gene of Stenotrophomonas maltophilia BM2690 encoding an aminoglycoside 6-N-acetyltransferase was characterized. The gene was identified as a coding sequence of 462 bp corresponding to a protein with a calculated mass of 16,506 Da, a value in good agreement with that of ca. 16,000 found by in vitro coupled transcription-translation. Analysis of the deduced amino acid sequence indicated that the protein was a member of the major subfamily of aminoglycoside 6-N-acetyltransferases. The enzyme conferred resistance to amikacin but not to gentamicin, indicating that it was an AAC(6) of type I. The open reading frame upstream from the aac(6)-Iz gene was homologous to the fprA gene of Myxococcus xanthus (61% identity), which encodes a putative pyridoxine (pyridoxamine) 5-phosphate oxidase. Pulsed-field gel electrophoresis of total DNA from BM2690 and S. maltophilia ATTC 13637 digested with XbaI, DraI, and SpeI followed by hybridization with rRNA and aac(6)-Iz-specific probes indicated that the gene was located in the chromosome. The aac(6)-Iz gene was detected by DNA-DNA hybridization in all 80 strains of S. maltophilia tested. The MICs of gentamicin against these strains of S. maltophilia were lower than those of amikacin, netilmicin, and tobramycin, indicating that production of AAC(6)-Iz contributes to aminoglycoside resistance in S. maltophilia.
Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) is a free-living, ubiquitous, nonfermentative gramnegative bacillus. It is an important opportunistic nosocomial pathogen in neutropenic, immunocompromised, and debilitated patients. S. maltophilia is associated with a wide variety of clinical infections, including bacteremia, endocarditis, meningitis, respiratory and urinary tract infections, and wound sepsis (13) . More recently, increasing chronic colonization by this bacterial species of the lower respiratory tract in patients with cystic fibrosis has been reported (2, 12) .
S. maltophilia is characteristically resistant to most broadspectrum antimicrobial agents, including aminoglycosides, carbapenems, cephalosporins, penicillins, and quinolones. These antibiotics are seldom used alone (13) , and synergism in vitro has been observed for certain combinations (5, 29, 49) . The resistance of S. maltophilia is mainly attributed to permeability barriers (8, 25, 47) . For instance, growth temperature-dependent variation in susceptibility to aminoglycosides, between 30 and 37°C, could be due to changes in the conformation of the outer membrane (30, 31, 46) . Efflux pumps could also play a role in multiple resistance, but this mechanism has not yet been documented in this species. In addition to intrinsic resistance by impermeability, S. maltophilia can inactivate antibiotics by synthesis of detoxifying enzymes. Metallo-␤-lactamases and cephalosporinases have been extensively investigated (9, 26, 36) , and modification of aminoglycosides by O-nucleotidylation and N-acetylation has been reported, but the responsible genes have not been identified (20, 45) . Among the various aminoglycoside-modifying enzymes, the AAC(6Ј) family is of particular interest, since it modifies antibiotics of therapeutic importance, such as amikacin, isepamicin, gentamicin, netilmicin, and tobramycin. The sequences of 22 aac(6Ј) genes encoding type I enzymes which modify amikacin but not gentamicin have been determined. Certain genes are associated with mobile elements, including plasmids, transposons, and integron cassettes (4, 40) , whereas others are species specific, such as aac(6Ј)-Ic of Serratia marcescens (41) ; aac(6Ј)-Ii of Enterococcus faecium (6); and aac(6Ј)-Ig, -Ij, -Ik, and -Ir to -Iw of proteolytic genomospecies of Acinetobacter (22, 23, 34, 35) . In this work, we describe the aac(6Ј)-Iz gene indigenous to S. maltophilia which contributes to aminoglycoside resistance in the species.
MATERIALS AND METHODS
Bacterial strains and plasmids. Epidemiologically unrelated clinical isolates of S. maltophilia from different sources, including strain BM2690 isolated from the sputum of a patient with cystic fibrosis, were used. The strains were isolated between 1992 and 1998 at the Hopital Saint Michel in Paris, France. Eight additional strains isolated from cystic fibrosis patients were from Hopital Robert Debré in Paris. S. maltophilia ATCC 13637 was also included in this study. Certain strains and plasmids used in this study are listed in Table 1 .
Strain identification and growth conditions. Identification was performed with API 20 NE strips (bioMérieux, La-Balme-les-Grottes, France). All the isolates were resistant to imipenem. The strains were grown in brain heart infusion broth (Difco Laboratories, Detroit, Mich.) or on Mueller-Hinton (MH) agar (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France). MH medium supplemented with 0.005% 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (IPTG) was used to detect production of ␤-galactosidase. MICs on MH agar containing serially twofold-diluted aminoglycosides were determined by the method of Steers et al. (42) with ca. 10 4 CFU per spot. The plates were incubated at 37°C for 18 h. The activity of 2Ј-and 6Ј-N-ethylnetilmicin was studied by diffusion on MH agar at 37°C with disks containing 100 g of antibiotic.
Assay for aminoglycoside-modifying enzymes. The activity of aminoglycosidemodifying enzymes was detected in bacterial extracts by the phosphocellulose paper-binding technique (17) . The reaction was allowed to proceed for 30 min at 30°C.
Genetic techniques. Transformation of Escherichia coli JM83 was performed as described previously (38) . The antibiotics for selection were ampicillin (100 g/ml) and tobramycin (5 g/ml).
Preparation and analysis of DNA. Isolation of total DNA and small-and large-scale preparation of plasmid DNA was done as described previously (38) . Electrophoresis was performed in 0.8% agarose gels (Sigma Chemical Co., St. Louis, Mo.) with a Tris-borate buffer system.
For the analysis of total DNA by pulsed-field gel electrophoresis (PFGE), strains were grown in 2-ml volumes of brain heart infusion broth. After centrifugation at 32 ϫ g for 10 min, the cell pellet was suspended in 750 l of 10 mM Tris base, 10 mM EDTA, 10 mM EGTA, 1 M NaCl (pH 7.5). Agarose plugs were made from a 1:1 mixture of 1.8% insert agarose (FMC BioProducts, Rockland, Maine) and the cell suspension. Each plug was placed in 1 ml of lysis buffer (6 mM Tris-HCl, 1 M NaCl, 100 mM EDTA, 0.5% Brij 58 [Sigma], 0.2% deoxycholic acid [Sigma], 0.5% N-lauroyl sarcosine [Sigma], 1 mg of lysozyme [Sigma]/ ml) for 1 h at 37°C. Genomic DNA in agarose plugs was then treated for 16 h at 55°C with 1 ml of TE buffer (10 mM Tris base, 1 mM EDTA) containing 100 g of proteinase K (Sigma). After three 1-h washes with TE buffer, the plugs were stored in TE buffer at 4°C. The plugs were digested with 20 U of restriction enzyme DraI, XbaI, or SpeI (Boehringer, Mannheim, Germany) for 20 h at 37°C. They were then loaded into the wells of a 0.8% agarose gel in 45 mM Tris-borate, 1 mM EDTA (pH 8.0), and genomic DNA was separated by PFGE at 4.5 V/cm for 21 h at 14°C with a Chef DRIII apparatus (Bio-Rad, Ivry-sur-Seine, France). The pulse time was 5 to 50 s with linear ramping. Lambda ladder PFGE I (Boehringer) was incorporated as a size standard. The electrophoresis products were visualized by ethidium bromide staining for 30 min.
DNA techniques. For dot blotting and Southern hybridization, DNA was immobilized on Nytran membranes (Schleicher & Schuell, Dassel, Germany). Prehybridization and hybridization were carried out as described previously (38) . The aac(6Ј)-Iz-specific probe was obtained by amplification of a 367-bp fragment by PCR from plasmid DNA obtained from E. coli JM83/pAT680 with primers 5Ј TGTACCCGTGATCGCCA and 5Ј ACTGTCCGAAGCCAGTT deduced from the sequence shown in Fig. 1 . PCR was performed in a DNA Thermal Cycler 480 (Perkin-Elmer Cetus, Norwalk, Conn.) with primer annealing at 55°C, as described previously (28) . The 367-bp fragment was separated by electrophoresis in low-temperature-gelling agarose type VII (Sigma), extracted and purified with a Qiagen (Chatsworth, Calif.) kit, and radiolabeled with [␣-
32 P]dCTP with the nick translation kit from Bethesda Research Laboratories Inc. (Gaithersburg, Md.) as described previously (38) . The cDNA of the 16S and 23S rRNA of E. coli MRE 600 (Boehringer) was obtained with avian myeloblastosis virus reverse transcriptase (Boehringer) and radiolabeled with [␣-
32 P]dCTP according to the recommendations of the manufacturer. The physical link between aac(6Ј)-Iz and the pdxH-like gene was studied with primers C (5Ј AGCCAGATTGGCGCGTGG) and D (5Ј TAGACGACCCGTTCGGTCTC) located in these genes, respectively ( Fig. 1) , under PCR conditions similar to those indicated above.
DNA sequencing. The 1.1-kb PstI fragment was cloned into bacteriophage M13 derivatives (Boehringer) and sequenced by the dideoxynucleotide chain terminator technique with synthetic oligonucleotides and the Sequenase version 2.0 DNA-sequencing kit (United States Biochemical Corp., Cleveland, Ohio) according to the recommendations of the manufacturer. DNA fragments were resolved by electrophoresis on 8% polyacrylamide gels containing 8 M urea. Nucleotide and amino acid sequences were analyzed and compared by using the GenBank, EMBL, and Swiss-Prot databases with the FASTA program (Genetics Computer Group, Madison, Wis.).
Analysis of plasmid-encoded proteins. The proteins specified by the recombinant plasmids were synthesized in a coupled in vitro transcription-translation system (50) . The proteins were labeled with L-[
35 S]methionine and processed for electrophoresis in a sodium dodecyl sulfate-polyacrylamide gel as described previously (38) .
Enzymes and chemicals. T4 DNA ligase was from Amersham (Little Chalfont, Buckinghamshire, England), lysozyme was from Sigma Chemical Co., and RNaseA (bovine pancreas) was from Calbiochem-Behring (La Jolla, Calif.). 
RESULTS AND DISCUSSION
Aminoglycoside resistance of S. maltophilia BM2690. The MICs of aminoglycosides against S. maltophilia BM2690 indicated that amikacin, isepamicin, netilmicin, and tobramycin were slightly less active against this strain than gentamicin ( Table 2) . Similar results were observed for most S. maltophilia strains ( Table 3 ). The variability in aminoglycoside MICs could be due to alterations in penetration of the antibiotics in the cells, as has been observed in Pseudomonas spp. Disk-agar diffusion tests indicated that the activity of 2Ј-N-ethylnetilmicin against S. maltophilia BM2690 was diminished compared with that of 6Ј-N-ethylnetilmicin. These two compounds have similar intrinsic activities against aminoglycoside-susceptible strains, and the difference observed can be taken as evidence for production of a 6Ј-N-acetyltransferase.
Aminoglycoside-modifying enzyme in S. maltophilia BM2690. Extracts of S. maltophilia BM2690 were shown to contain aminoglycoside acetyltransferase activity. The substrate profile of the enzyme was consistent with an AAC(6Ј)-I, since amikacin, gentamicins C1a and C2, isepamicin, kanamycin B, netilmicin, tobramycin, and 2Ј-N-ethylnetilmicin were modified whereas gentamicin C1 and 6Ј-N-ethylnetilmicin were not (data not shown).
Cloning and sequencing of the aac(6)-I gene. Total DNA from BM2690 and pUC18 DNA were digested with PstI, mixed, ligated, and introduced by transformation into E. coli JM83. Transformants selected on medium containing ampicillin plus tobramycin were screened for their plasmid content by agarose gel electrophoresis of crude bacterial lysates. The (Fig. 1) . Two potential translation initiation codons, CTG and GTG, were located at positions 366 and 390, respectively, but neither was preceded by a typical ribosome binding site. This may account for the low-level aminoglycoside resistance observed in E. coli JM83/pAT680 (Table 1) . Promoter sequences were not readily apparent by analysis of the region upstream from aac(6Ј)-Iz; a putative promoter may consist of Ϫ35 (TT GGCG) (position 149 to 154) and Ϫ10 (TCGAAG) motifs separated by 17 nucleotides (the underlined nucleotides indicate identity with the consensus Ϫ35 and Ϫ10 promoter elements recognized by the E. coli 70 factor). It is also possible that aac(6Ј)-Iz and a pdxH-like gene form a single transcription unit, similar to aacC3 and cysC in Pseudomonas aeruginosa (44) . (Fig. 2) . The relatedness of the major subfamily AAC(6Ј)-I is shown in Fig. 3 . Analysis of the protein deduced from the second ORF. The deduced C-terminal portion of the putative protein encoded by the truncated DNA sequence upstream from the aac(6Ј)-Iz gene had homology with pyridoxine (pyridoxamine) 5Ј-phosphate oxidase proteins found in M. xanthus (18) (61% identity), Saccharomyces cerevisiae (24) (43% identity), and E. coli (21) (39% identity). It is likely that this DNA corresponds to the analogous gene in S. maltophilia. Pyridoxine (pyridoxamine) 5Ј-phosphate oxidase is a key enzyme in biosynthesis of the essential coenzyme pyridoxal 5Ј-phosphate, which participates in many aspects of amino acid metabolism. The fact that, in S. maltophilia BM2690, aac(6Ј)-Iz was adjacent to a gene involved in essential host metabolism strongly suggests a chromosomal location for that gene. Furthermore, the GϩC content of the aac(6Ј)-Iz was 69% similar to that of S. maltophilia, in agreement with an indigenous origin of this gene.
Distribution and location of the aac(6)-Iz gene. Total DNA from 80 S. maltophilia strains was spotted on a Nytran membrane and hybridized with an intragenic aac(6Ј)-Iz probe. The gene was found to be present in all the strains (data not shown). To determine the location of the aac(6Ј)-Iz gene, PFGE was performed with total DNA of S. maltophilia BM2690 and ATCC 13637 digested with XbaI, DraI, and SpeI. The fragments were transferred to Nytran membranes and hybridized successively with an rRNA and an aac(6Ј)-Iz probe (Fig. 4) . The aac(6Ј)-Iz gene was located in a ca. 510-kb XbaI fragment in S. maltophilia BM2690 and in a ca. 680-kb SpeI fragment in S. maltophilia ATCC 13637 which cohybridized with the rRNA probe. These results confirmed that the aac(6Ј)-Iz gene was located in the chromosome of S. maltophilia. In addition, the adjacent location of aac(6Ј)-Iz and pdxH-like genes in the remaining strains of S. maltophilia was demonstrated by amplification of a 676-bp fragment with primers C, specific for pdxH, and D, specific for aac(6Ј)-Iz (data not shown).
Conclusions. Like S. marcescens (41) , E. faecium (6) , and the various species of proteolytic Acinetobacter (35), S. maltophilia harbors a "housekeeping" aac(6Ј)-I. This gene, probably weakly expressed, contributes to aminoglycoside resistance in this species as indicated by the slight difference in susceptibility to gentamicin and to the other aminoglycosides ( Table 3 ). The origin of aminoglycoside resistance genes is still a matter of controversy (33) . A possibility is that they derive from antibiotic-producing microorganisms in which they are required for self-protection against the toxic aminoglycosides (3, 7, 10). Alternatively, they could derive from housekeeping genes involved either in cellular metabolism or in peptidoglycan or lipopolysaccharide metabolism (27) . These two hypotheses are not mutually exclusive, and there are strong arguments in favor of each proposal, depending on the bacterial species considered. It has been established that the resident AAC(2Ј)-Ia in Providencia stuartii can O-acetylate peptidoglycan (27, 32) , and a similar function for the AAC(2Ј)-Id of Mycobacterium segmatis is possible (1) . The functional role, if any, of AAC(6Ј)-Iz in S. maltophilia remains unknown.
